Figure 7: The interaction between doxorubicin against epidermal growth factor receptor. The ligand can interact with the key amino acid of epidermal growth factor receptor (Lys721, Thr766, Met769, Thr830) through a hydrogen bond[10]
![Figure 7: The interaction between doxorubicin against epidermal growth factor receptor. The ligand can interact with the key amino acid of epidermal growth factor receptor (Lys721, Thr766, Met769, Thr830) through a hydrogen bond<sup>[10]</sup>](articles/2022/13/3/images/JAdvPharmTechRes_2022_13_3_141_349836_f7.jpg)
| Close | |
|
|
|
|
Figure 7: The interaction between doxorubicin against epidermal growth factor receptor. The ligand can interact with the key amino acid of epidermal growth factor receptor (Lys721, Thr766, Met769, Thr830) through a hydrogen bond[10]
|
|